Special notice
Intent to Sole Source - Amyloid Florbetaben Injections
36C24824Q1585
Department of Veterans Affairs, 248-Network Contract Office 8. Pharmaceutical Preparation Manufacturing.
Awarded
$282,152.00 obligated so far on USAspending
Get the next one like this from Department of Veterans Affairs by email, the day it is posted.Find my opportunities
This one was awarded in 2024
9 like it are open now in pharmaceutical preparation manufacturing
- FY27 Low Energy General Radiopharmaceuticals 36C25027Q0052
Department of Veterans Affairs, 250-Network Contract Office 10
Sources soughtNAICS 325412Anywhere in the US36C25027Q0052Closes tomorrowNov 3 - Sacubitril/Valsartan Tablets (VA-27-00014055)
Department of Veterans Affairs, Nac Pharmaceuticals
PresolicitationNAICS 325412Anywhere in the US36E79727R0007Closes tomorrowNov 3 - LIDOCAINE 5% PATCHES-REQUEST FOR INFORMATION
Department of Veterans Affairs, National Cmop Office
Sources soughtNAICS 325412Anywhere in the US36C77027Q0010Closes tomorrowNov 3
Description
As published on SAM.gov.
Page 2 of 2 This is not a solicitation for quotes. This is a Special Notice. The purpose of this Special Notice is to provide notification of the Department of Veterans Affairs (VA) intent of contract action to make a sole source award in accordance with FAR Part 6.302-1.
Special Notice of Contract Action: Network Contracting Office (NCO) 8 intends to issue a sole source, firm fixed price contract with a base year and four option years, using other than full and open competition, to SOFIE, Co. for the purchase of FDA approved Neuraceq Florbetaben F-18 Injections for the VA Healthcare Center Miami. Estimated value of this acquisition is approximately $110,000.00/year and $550,000/including base and option years.
The estimated award date is on or before October 01, 2024. Qualified sources may submit a quote (or capabilities statement) which shall be considered but shall in no way bind the agency. Reimbursement will not be made for any costs associated with providing or requesting information in response to this Special Notice. Responses shall be submitted via email to Melissa.Everett@va.gov and received no later than 5:00 PM on Friday, September 6, 2024.
The contract, on USAspending
Federal procurement data the awarding office reported to FPDS, matched to this solicitation by its number.
- Recipient
- Sofie Co.
- UEI
- JV1AHJHGUGG3
- CAGE
- 09QR8
- Vendor location
- Dulles, VA
- Contract
- 36C24825P0009, purchase order
- Obligated
- $282,152.00, current value $282,232, potential $601,989
- Actions
- 8 between October 1, 2024 and October 1, 2026
- Competition
- Not Competed, 1 offer received
- Set-aside reported
- No Set Aside Used.
- Described as
- Amyloid Florbetaben Injections Radiopharmaceutical
- Match
- solicitation number 36C24824Q1585 equals the FPDS solicitation identifier; same awarding office 36C248 (high confidence)
- Record
- USAspending award page
Publications
Every notice SAM.gov issued under this solicitation number, oldest first. Each is a separate record on SAM.
August 30, 2024
Special notice
Due September 6, 2024 at 5:00 PM EDT. SAM.gov, notice c4652c8405904bb0acc36fff72c88569
Points of contact
- Melissa Everett, Contract Specialistmelissa.everett@va.gov561-628-6754